EcoSynthetix Inc. - Third Quarter 2026 Earnings Call - DEFI TECHNOLOGIES INC

Explicit Guidance:

• No formal quantitative financial guidance (revenue, earnings, margins, capex) was issued for FY 2026 or FY 2027.
• Share Repurchases: The Board has committed to up to 500,000 CAD in share purchases via the NCIB (Normal Course Issuer Bid) specifically for Q4 2026, with quarterly reviews of this allocation to be conducted moving forward.

Business-Segment Outlook:

• Tissue: First North American tissue mill proof point achieved; commercial orders on a continuous basis started in August 2026 following trials initiated in January 2026 (approx. 8-month cycle). Revenue opportunity per line estimated at $200,000–$300,000 annually.
• Pulp (Hardwood/Softwood): Revenue recovery expected only when the price spread between softwood and hardwood pulp reverts to historical norms (> $200/ton), a shift currently uncertain in timing. Conversion to the customer's enhanced pulp is described as "sticky," implying a return to full volume once pricing dynamics improve.
• Wood Composites (Durabind): An international retailer remains committed to 2030 sustainability goals but reduced volumes due to cost sensitivity. An enhanced cost-reducing formulation is undergoing trials later in 2026. The total opportunity for the customer's change agenda is approximately $60 million across 17 production lines (4 mills).
• Packaging: Commercial trials with a major producer are underway in North America; adoption expected to be slower than tissue but showing promising results.

Market and Competitive Outlook:

• Pricing Dynamics: The industry currently faces an unusual price compression where 40% of softwood pulp is sold below cash costs. Management anticipates this will correct as softwood capacity curtails and hardwood capacity expands (particularly in Brazil and Indonesia), restoring normal pricing spreads.
• Demand Shifts: Anticipated shift in global fiber demand favoring hardwood over softwood, driven by faster growth rates and processing efficiency of hardwood, though cyclical oversupply is currently suppressing the premium.
• Commercialization Pace: Management notes that the "pipe" for trials is expanding but moving slower than normal due to market headwinds. However, trial activity volume is higher than prior years due to the addition of new distribution partners.
• Tissue Segment: Viewed as the primary growth driver in the near term due to value propositions beyond hardwood/softwood spreads (energy reduction, runnability improvements, dust reduction).

Macro / Industry Outlook:

• Economic Conditions: Continued "global affordability crisis" and soft end-market demand are dampening adoption rates and pricing power.
• Commodity Costs: Oil prices hovering near $100/barrel and rising corn prices are creating cost disadvantages for incumbent oil-based and corn-based chemicals, potentially opening opportunities for biopolymers in the Asia market (specifically regarding supply security for styrene-based latex).
• Regulatory/Trends: Strong tailwinds expected for formaldehyde elimination and carbon footprint reduction in household products; management views these as industry necessities rather than optional differentiators.

Strategic Initiatives:

• Product Innovation (Durabind): Next-generation formulation targeting cost and sustainability improvements; retailer to begin trials in the coming quarter (Q4 2026).
• Product Innovation (Surflok): Development of variations for specific geographies and fiber furnishes (tissue, packaging, pulp) entering commercial trials.
• Personal Care: Partner Dow plans to launch a new "MaizeCare" product for all-natural ingredient applications in spring 2027 during personal care show season.
• Distribution Expansion: New partners signed in South America; active relationship building in Asia, U.S., and Canada.
• Personnel: Recruited an experienced leader for Surflok business development; added an R&D leader with specific core market experience.
• Capacity/Operations: Retailer partner investing in upgrading a large production line to support the bio-based glue system.

Risks and Headwinds to Outlook:

• Pricing Spread Volatility: Continued narrow spreads between hardwood and softwood pulp prices may delay the return of the "commercial incentive" for enhanced pulp products, delaying revenue recovery.
• Customer Concentration: Two strategic accounts currently represent >100% of the year-over-year sales decline; their cost-reduction strategies pose an immediate execution risk.
• Trial Duration: Adoption timelines in pulp and packaging remain "long" due to the complexity of industrial processes and the need for site-specific validation (geography and fiber furnish variations).
• Market Saturation: The "dampener" on trial activity is a broad industry issue, not just company-specific, as distributors face general market conditions that do not favor value proposition switching.

Management Tone on the Future:

• Confidence Level: Cautiously optimistic on long-term value ("products have been proven to work") but realistic about near-term headwinds. Acknowledged current results are "not acceptable."
• Strategic Focus: Shift from waiting for market conditions to proactively accelerating innovation and commercialization ("building position proactively rather than simply waiting").
• Execution Philosophy: Emphasis on "measured" capital allocation (share repurchases) to preserve cash for growth, acknowledging the uncertainty of the recovery timing.
• Timeline Expectations: Expectation that market conditions will "shift over time," but no immediate change is forecast. Specific commercialization milestones (e.g., tissue expansion, pulp trials) are targeted for 2027.

Miscellaneous:

• Financial Position: Cash and term deposits of $29.4 million as of Sept 30, 2026.
• Capital Allocation: $766,000 invested YTD to repurchase 329,000 shares; $33,000 invested in Q3 to retire 23,000 shares.
• Cost Structure: Gross profit margin improved to 37.8% (vs. 34.2% prior year) due to product mix and higher ASP, despite a 36% drop in gross profit dollars due to volume decline.